PEB Share Price

Open 0.52 Change Price %
High 0.52 1 Day 0.00 0.00
Low 0.52 1 Week 0.01 1.96
Close 0.52 1 Month 0.08 18.18
Volume 127705 1 Year 0.07 15.56
52 Week High 0.67
52 Week Low 0.38
PEB Important Levels
Resistance 2 0.52
Resistance 1 0.52
Pivot 0.52
Support 1 0.52
Support 2 0.52
NZE NewZealand Most Active Stocks
ATM 2.28 -11.63%
ATM 2.28 -11.63%
ATM 2.28 -11.63%
ATM 2.28 -11.63%
NPX 5.45 0.55%
NPX 5.45 0.55%
NPX 5.45 0.55%
TEL 2.87 0.00%
TEL 2.87 0.00%
TEL 2.87 0.00%
More..
NZE NewZealand Top Gainers Stocks
MGL 0.02 100.00%
MGL 0.02 100.00%
OIC 0.93 5.68%
FPH 8.56 4.26%
FPH 8.56 4.26%
FPH 8.56 4.26%
MVN 1.31 3.97%
MVN 1.31 3.97%
OGC 3.97 3.12%
OGC 3.97 3.12%
More..
NZE NewZealand Top Losers Stocks
ATM 2.28 -11.63%
ATM 2.28 -11.63%
ATM 2.28 -11.63%
ATM 2.28 -11.63%
HBY 3.20 -3.03%
HBY 3.20 -3.03%
SDL 2.30 -2.13%
SDL 2.30 -2.13%
SDL 2.30 -2.13%
SKT 4.66 -1.89%
More..

Pacific Edge Ltd (NZE: PEB)

PEB Technical Analysis 1.5
As on 2nd Dec 2016 PEB Share Price closed @ 0.52 and we RECOMMEND Sell for LONG-TERM with Stoploss of 0.53 & Buy for SHORT-TERM with Stoploss of 0.48 we also expect STOCK to react on Following IMPORTANT LEVELS.
PEB Target for December
1st Target up-side 0.59
2nd Target up-side 0.64
3rd Target up-side 0.69
1st Target down-side 0.43
2nd Target down-side 0.38
3rd Target down-side 0.33
PEB Other Details
Segment EQ
Market Capital 0.00
Sector Healthcare
Industry Medical Laboratories & Research
Offical website http://www.pacificedge.co.nz
PEB Address
PEB
87 Saint David Street
PO Box 56
Dunedin, 9016
New Zealand
Phone: 64 3 479 5800
Fax: 64 3 479 5801
PEB Latest News
Following the Numbers on Shares of Pacific Edge Limited (NZSE:PEB)   Marion Business Daily   - 02nd Dec 16
Chris Gallaher Elected New Chairman for Pacific Edge Board   Scoop.co.nz (press release)   - 25th Aug 16
Pacific Edge Presents Positive Cxbladder Monitor™ Results   PR Newswire (press release)   - 17th May 16
Pacific Edge signs huge deal with Veterans Health Administration   Otago Daily Times   - 29th Feb 16
Brokers downgrade Pacific Edge views   Otago Daily Times   - 08th Nov 15
Pacific Edge share price back near 46c   Otago Daily Times   - 09th Sep 15
Pacific Edge seeks 'last' capital raising   Otago Daily Times   - 07th Jun 15
Research Shows Pacific Edge's Cxbladder Detect Outperforms Other Non-Invasive ...   PR Newswire (press release)   - 26th May 15
Pacific Edge's Cxbladder Triage™ Accurately Stratifies Patients with Bladder ...   PR Newswire (press release)   - 19th May 15
Pacific Edge's Cxbladder™ Boosting Confidence in Bladder Cancer Detection   PR Newswire (press release)   - 29th Jan 14
Interactive Technical Analysis Chart Pacific Edge Ltd ( PEB NZE NewZealand )
Java support must be enabled in order to display FnCharts.
You can download Java from http://www.java.com
Your Comments and Response on Pacific Edge Ltd
PEB Business Profile
Pacific Edge Limited, a biomedical company, engages in the discovery, development, and commercialization of diagnostic and prognostic tools for the early detection and management of cancer. It offers Cxbladder, a non-invasive urine based test for the detection of bladder cancer; and Cxcolorectal, a prognostic gene signature for patients diagnosed with stage II or stage III colorectal cancer. The company’s products in development and clinical trial stage include gastric cancer diagnosis and prognosis, gastric cancer triage, and melanoma diagnosis and prognosis. It also manages and operates laboratories for the detection of bladder cancer. The company was formerly known as Pacific Edge Biotechnology Limited and changed its name to Pacific Edge Limited in April 2010. Pacific Edge Limited was founded in 2001 and is based in Dunedin, New Zealand.